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Abstract
Pleural tuberculosis (TB), together with lymphatic TB, constitutes more than half of all extrapulmonary cases. Pleural
effusions (PEs) in TB are representative of lymphocytic PEs which are dominated by T cells. However, the mechanism
underlying T lymphocytes homing and accumulation in PEs is still incompletely understood. Here we performed a
comparative analysis of cytokine abundance in PEs from TB patients and non-TB patients by protein array analysis and
observed that MCP-2/CCL8 is highly expressed in the TB-PEs as compared to peripheral blood. Meanwhile, we observed that
CCR5, the primary receptor used by MCP-2/CCL8, is mostly expressed on pleural CD4+ T lymphocytes. Furthermore, we
found that infection with either Mycobacterium bovis Bacillus Calmette-Gue´rin (BCG) or Mycobacterium tuberculosis H37Rv
induced production of MCP-2/CCL8 at both transcriptional and protein level in Raw264.7 and THP-1 macrophage cells,
mouse peritoneal macrophages as well as human PBMC monocyte-derived macrophages (MDMs). The induction of MCP-2/
CCL8 by mycobacteria is dependent on the activation of TLR2/PI3K/Akt and p38 signaling pathway. We conclude that
accumulation of MCP-2/CCL8 in TB-PEs may function as a biomarker for TB diagnosis.
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Introduction
Tuberculosis (TB) continues to prevail as a major cause of
mortality around the world killing almost 1.5 million people
annually. Despite implementation of control programs and the
availability of effective drugs, some 14% of TB patients suffer from
tuberculous pleuritis, which presents as an acute illness character-
ized by fever, cough, pleural chest pain and pleural effusions (PEs).
TB-PEs occur in approximately 2–10% of TB patients, which may
result from primary or reactivation TB [1,2]. The development of
PEs is often associated with the accumulation of fluid enriched in
proteins and cells in the pleural space [3]. It has been well
documented that TB and cancer represent the two most frequent
causes of exudative PEs predominated by lymphocytes in pleural
fluid; whereas PEs during acute infections, including empyema
and parapneumonic effusions, are typically characterized by influx
of neutrophils [4,5]. It is well known that bacterial, host and
environmental factors influence the development of TB [6]. TB-
PEs are caused by severe delayed-type hypersensitivity (DTH)
reactions to the rupture of the subpleural focus of Mycobacterium
tuberculosis (Mtb) infection. An improved understanding of the
immunopathogenesis of TB-PEs can accelerate development of
novel immunodiagnostic tools and therapeutic interventions.
The T cell response is a critical component of protective
immunity against Mtb [7]. During mycobacterial infections, a
strong CD4+ type 1 helper (Th1)-like immune response with
prominent interferon-gamma (IFN-c) secretion is considered
critical for the containment of Mtb by means of activation of
infected macrophages by Th1-type cytokines. However, Th1 cells
alone do not explain the resistance/susceptibility to Mtb infection
and TB disease [8]. Increasing evidence suggests that several Th
subsets, including Th17 cells [9], regulatory T cells[10], Th9 cells
[11] and Th22 cells [12], are involved in the pathogenesis of TB-
PEs. A healthy pleural fluid contains few, if any, T cells. However,
in TB-PEs, T cells preponderate, which are sequestrated in this
compartment from both systemic and pulmonary vasculature on
the visceral pleural surface and from systemic vessels from the
parietal pleural surface. Homing of T cells to sites of infection and
inflammation is incompletely understood.
Chemokines are proinflammatory cytokines of low molecular
size, which orchestrate migration and activation of different
leukocyte populations. On the basis of the number and
arrangement of conserved cysteins, chemokines can be divided
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into four groups; CXC, CC, C, and CX3C. Both the CXC and
CC families contain many members, whereas lymphotactin and
fractalkine/neurotactin are at present the only known C and
CX3C chemokines, respectively. It has been reported that multiple
chemokines expressed in the TB-PEs, including CXC chemokines
such as IFN-c-inducible protein of 10-kD (IP-10/CXCL10),
monokine induced by IFN-c (MIG/CXCL9), IFN-inducible T-
cell alpha chemoattractant (I-TAC/CXCL11), interleukin-8 (IL-
8/CXCL8), as well as CC chemokiines such as macrophage
inflammatory protein-1 alpha (MIP-1alpha/CCL3), regulated
upon activation normal T lymphocyte expressed and secreted
(RANTES/CCL5) and monocyte chemotactic protein 1 (MCP-1/
CCL2) [13,14,15,16,17]. Here we performed a protein array
analysis of cytokine abundance in the PEs from TB patients and
non-TB patients, and firstly identified MCP-2/CCL8 as a
significantly higher expressed chemokine in the TB-PEs. MCP-
2/CCL8 is a proinflammatory chemokine, which is expressed in
inflamed tissues by resident and infiltrated cells (primarily
monocyte/macrophages) after paracrine stimulation from T-cells
by IFNs and other proinflammatory cytokines, or through innate
mechanisms upon contact with viral, bacterial and fungal agents
[18,19]. It is chemotactic for, and activates, different cell types,
including granulocytes and mononuclear phagocytes, through
various chemokine receptors, including chemokine receptors
CCR1, CCR2B and CCR5 [20,21,22]. In this study, we describe
the source and regulation of MCP-2 as well as the expression of
CCR5, which is the primary receptor of MCP-2 on cells
accumulated in TB-PEs. Our study provides first hints on the
role of MCP-2/CCL8 in the pathogenesis of pleural TB.
Results
Elevated MCP-2/CCL8 expression in TB-PEs
To understand the pathogenesis of pleural TB, we performed a
protein array analysis to examine the expression of a total of 40
different cytokines between PEs from TB patients and those from
non-TB patients, including cancer, pneumonia, and pulmonary
arterial hypertension (PAH) (Fig.1 A, Table 1). Concentrations
of eight cytokines including I-309/CCL1, RANTES/CCL5,
MCP-2/CCL8, IL-8/CXCL8, MIG/CXCL9, MCP-1/CCL2,
IFN-c and PDGF-BB, were significantly elevated in TB-PEs
(Fig.1 B). We then examined the expression of these cytokines by
ELISA in PEs from 13 definite TB patients and 12 control patients
in whom TB was definitely excluded. Pleural IFN-c has been
suggested for diagnosis of TB-PEs [23]. We consistently found
higher expression of IFN-c in TB-PEs than in non-TB-PEs (Fig.1
C). We also firstly observed the presence of MCP-2/CCL8 in TB-
PEs and identified it as a significant higher expressed chemokinein
the TB-PEs as compared to malignant PEs (Fig.1 D). However,
MCP-2/CCL8 expression was low in the plasma of TB patients
either with or without PEs, comparable to healthy donors (Fig.1
E). These results suggest that MCP-2 accumulates in TB-PEs.
We next analyzed the diagnostic value of MCP-2/CCL8 in
differential diagnoses of TB-PEs and PEs with the other etiologies.
Using the receiver operating characteristic (ROC) curve, we noted
that the area under curve (AUC) was 1.0 for MCP-2/CCL8 and
0.987 for IFN-c in TB-PEs. With this cut-off value of 22.78 pg/ml
for MCP-2/CCL8 and of 14.75 pg/ml for IFN-c, sensitivity and
specificity of MCP-2/CCL8 for TB-PEs were both 100%. Thus,
MCP-2/CCL8 is a candidate marker for differential diagnosis of
TB-PEs.
Elevated percentage of CCR5-expressing CD4+ T cells in
TB-PEs
MCP-2/CCL8 is a proinflammatory chemokine that activates
different cell types through various chemokine receptors, including
CCR5. CCR5 has a promiscuous ligand-binding repertoire and is
the primary receptor used by MCP-2/CCL8 on activated T cells
[21]. Consistent with previous findings, TB-PEs were rich in
lymphocytes, especially T cells (68.8%626.7%, n= 6) (Fig. 2A).
Both CD4+ and CD8+ T cells were found in TB-PEs, with CD4+
T cells being dominant (49.6%619.2% vs 19.6%612.8%, n= 6)
(Fig. 2A). CCR5 was highly expressed on CD3+T lymphocytes
but rarely on CD32 lymphocytes in TB-PEs (Fig. 2B), and both
CD4+ and CD8+ T cells expressed CCR5 (Fig. 2B). The
percentages of CCR5-expressing CD3+ cells and CD4+ T cells in
TB-PEs were significantly higher than those in malignant PEs
(6.57%61.02% vs 2.47%60.36%, n= 6, p,0.05; 5.30%60.84%
vs 1.67%60.25%, n= 6, p,0.05). Whereas expression of CCR5
on CD8+ T cells from TB-PEs and malignant PEs did not differ
significantly (1.27%60.21% vs 0.80%60.26%, n= 6, p.0.05)
(Fig. 2E). Meanwhile, we detected the expression of CCR1 and
CCR2, which are reported to be functional receptor of MCP-2/
CCL8 [22], on T cells. We observed that CCR1 was expressed on
both CD3+ and CD32 lymphocytes (Fig. 2C). In addition, the
expression of CCR1 on CD3+, CD4+ and CD8+ T cells from TB-
PEs was not significantly different from those from malignant PEs
(Fig. 2C, F). While there were very few expression of CCR2 on
lymphocytes from either TB-PEs or malignant PEs (Fig. 2D).
Also the expression of CCR2 on different subsets of cells from TB-
PEs is equivalent to those from malignant PEs. These results
suggest that MCP-2/CCL8 recruits CD4+ T lymphocytes to TB-
PEs through activating its primary receptor CCR5 instead of
CCR1 or CCR2.
Mycobacteria -induced MCP-2/CCL8 expression in
macrophages
Macrophages are the primary target of the causative agent of
TB,Mtb [24,25,26], and they have been found in TB-PEs [27]. To
test whether Mtb infected macrophages are the origin of the
elevated MCP-2/CCL8 in TB-PEs, we infected Raw264.7 cells, a
murine macrophage cell line, with either M. bovis BCG or M.
tuberculosis H37Rv at MOI 5. The mRNA level of mcp-2/ccl8 in
these mycobacteria-infected macrophage cells were analyzed by
real-time RT-PCR (Fig. 3A–B). BCG or H37Rv infection
induced mcp-2/ccl8 mRNA at different time points (Fig. 3A–B).
We also investigated whether M. tuberculosis H37Rv induced the
synthesis of other elevated cytokines including MCP-1/CCL2,
RANTES/CCL5, MIG/CXCL9, I-309/CCL1 and PDGF-BB in
Raw264.7 cells. I-309/CCL1 is undetectable in Raw264.7 cells
left untreated or treated with BCG. Other than a minor induction
of MIG/CXCL9 mRNA in Raw264.7 cells infected with BCG for
24 h, all other cytokines are not significantly induced (Fig. S1).
Therefore, macrophage may be the origin of MCP-2/CCL8
instead of MCP-1/CCL2, RANTES/CCL5, I-309/CCL1 and
PDGF-BB. Next, we infected murine primary peritoneal macro-
phages with either BCG or H37Rv at MOI 5 and also observed an
induction of the expression of mcp-2/ccl8 mRNA at indicated time
(Fig. 3C–D). To make sure whether MCP-2/CCL8 could be
induced by mycobacteria in human macrophages, we then
infected phorbol-12-myristate-13-acetate (PMA)-differentiated
THP1, a human acute monocytic leukemia cell line, with either
BCG or H37Rv respectively at MOI 5 for 24 h and 48 h, and
analyzed the production of MCP-2/CCL8 by ELISA. Both BCG
and H37Rv infection markedly induced release of MCP-2/CCL8
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protein from PMA-differentiated THP-1 macrophages (Fig. 3E–
F). Finally, we stimulated human PBMC monocyte-derived
macrophage (MDM) with either BCG or H37Rv and then
detected MCP-2/CCL8 released in the supernatant by ELISA.
We observed that the MCP-2/CCL8 protein expression in MDM
was also significantly induced by mycobacteria (Fig. 3G–H).
These results suggest that mycobacterial infection induces the
expression of MCP-2/CCL8 at both transcriptional and protein
levels in macrophages, which is of physiological relevance.
Induction of MCP-2/CCL8 by mycobacteria through
activation of p38 and PI3K/Akt
To elucidate the mechanisms underlying induction of MCP-2/
CCL8 by mycobacteria in macrophages, we first analyzed the
activation of MAPKs, including p38, ERK and JNK, the NF-kB
signaling pathway as well as PI3K/Akt signaling pathway in BCG-
infected murine primary peritoneal macrophages by immunoblot
using anti-phosphor antibodies. We observed that BCG infection
activates all these signaling pathways (Fig. 4A). We also observed
that H37Rv infection activates all these signaling pathways in a
Figure 1. High MCP-2/CCL8 abundance in TB-PEs. (A) Diagram showed that PEs from both TB and non-TB patients were applied to protein chip
assays to screen differentially expressed cytokines. Data were subsequently confirmed by ELISA. (B) Differentially expressed proteins in PEs from TB
patients and non-TB patients. (C–D) ELISA of IFN-c (C) or MCP-2/CCL8(D) in the PEs from TB or non-TB patients. (E) ELISA of MCP-2/CCL8 protein in the
peripheral blood from TB patients with or without PEs and healthy donors. (F) Receiver operating characteristic curve showing the area under curve
(AUC) of MCP-2/CCL8 and IFN-c. **, p,0.001, *, p,0.05.
doi:10.1371/journal.pone.0056815.g001
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similar way (Fig. 4B). To determine which signaling pathway is
involved in the induction of MCP-2/CCL8 by mycobacteria, we
infected THP-1 cells with BCG in the absence or presence of PI3K
inhibitor (LY294002, 10 mM), ERK inhibitor (PD980259, 10 mM),
JNK inhibitor (SP600125, 10 mM), p38 inhibitor (SB203580,
10 mM) or NF-kB inhibitor (BAY11-7082, 10 mM),and then
detected the release of MCP-2/CCL8 in the supernatant by
ELISA. Intriguingly, the induction of MCP-2/CCL8 was mark-
edly inhibited by either SB203580 or LY294002. We also
observed that SB203580 and LY294002 inhibited BCG-induced
MCP-2/CCL8 production in a dose-dependent manner (Fig.
S2). Whereas, inhibition of ERK by PD98059 or inhibition of
NF-kB by BAY11-7082 only partially inhibited the induction of
MCP-2/CCL8 (Fig. 4C). In addition, the inhibitory effect of
these compounds on the induction of MCP-2/CCL8 in THP-1
cells are not due to the cytotoxic effect since the percentage of
dead THP-1 cells treated with either DMSO or the inhibitors are
equivalent (Fig. S3A). We also replicated above experiment with
human PBMC MDMs and we observed similar phenomena
(Fig. 4D and Fig. S3B). However, the induction of mcp-2/ccl8
mRNA by BCG in Raw264.7 macrophages was significantly
inhibited by SB203580, but not any other inhibitor tested,
suggesting that activation of p38 is essential for the BCG-induced
transcription of mcp-2/ccl8 (Fig. S4). Taken together, mycobac-
terial infection induces MCP-2/CCL8 expression in macrophages
mainly through p38 and PI3K/Akt signaling pathways.
TLR2 mediates mycobacteria-induced MCP-2/CCL8
production in macrophages
Pattern recognition receptors (PRRs) play an important role in
the sensing of pathogens by means of pathogen associated
molecular patterns (PAMPs) and the initiation of immune
responses [28]. To interrogate which PRR is essential for
mycobacteria-induced MCP-2/CCL8 production in macrophag-
es, we compared mRNA levels of mcp-2/ccl8 among macrophages
from wild-type, TLR22/2, TLR32/2 or TLR42/2 mice after
infection with either BCG or H37Rv at an MOI 5 for 24 h. We
observed that the mcp-2/ccl8 mRNA level was significantly reduced
in macrophages from TLR22/2 mouse, but not in those from
TLR32/2 and TLR42/2 mice (Fig. 5A–B). Consistent with this
observation, phosphorylation of Akt and p38 was markedly
reduced in TLR22/2 mice (Fig. 5C–D). We therefore consider
TLR2-mediated phosphorylation of Akt and p38 essential for
induction of MCP-2/CCL8 by BCG in macrophages.
Discussion
TB-related PEs are initiated once Mtb bacilli or antigen-derived
monocytes, neutrophils, and subsequently T cells thereof reach the
pleural space. Here we show that induction of MCP-2/CCL8 in
macrophages by mycobacteria depends on activation of TLR2/
PI3K/Akt and p38 signaling pathway. Furthermore, the highly
expressed MCP-2/CCL8 in the TB-PEs likely induces influx of
CD4+ T lymphocytes into TB-PEs by stimulated surface-
expression of CCR5, the primary receptor for MCP-2/CCL8
(Fig. 6).
Mtb antigens in pleural space elicit an intense immune response,
initially by macrophages and neutrophils [29,30] and followed by
Th1 cells [31]. This series of events results in lymphocyte-rich
exudative effusions. Accompanying the leukocyte infiltration,
cytokines, chemokines, growth factors, and other soluble media-
tors are enriched in these TB-PEs, as demonstrated by our
cytokine array results (Table 1). It is widely accepted that these
mediators orchestrate evolution of the disease, i.e., its resolution or
its progression to fibrosis. Among the 40 cytokines detected and
compared between TB and non-TB patients, 8 cytokines including
I-309/CCL1, RANTES/CCL5, MCP-2/CCL8, IL-8/CXCL8,
MIG/CXCL9, MCP-1/CCL2, IFN-c and PDGF-BB were
significantly higher expressed in TB-PEs. Intriguingly, 6 of the 8
cytokines were chemokines, emphasizing the important role of the
Table 1. Protein array analysis of cytokine abundance in PEs
from TB patients and non-TB patients (Values stand for
relative intensity of fluorescence).
Cytokines TB (n =4) Non-TB (n =4) p value
MEAN±SD MEAN±SD
I-309/CCL1 3165.1766914.1466 77.9323636.2464 0.000516
RANTES/CCL5 2109.0166908.365 432.25116274.1662 0.012303
PDGF-BB 515.39146218.1624 140.5112614.22901 0.013981
MCP-2/CCL8 7780.71964906.762 209.8403666.84131 0.021508
IL-8/CXCL8 6820.90764172.937 929.93926592.7471 0.031355
MIG/CXCL9 1094.8316404.285 524.69066146.5638 0.037946
IFN-gamma 1069.5316411.7542 496.75346139.3981 0.038788
MCP-1/CCL2 17483.3565633.848 8505.75763984.14 0.040548
IL-6 63399.42610537.73 33269.22625833.59 0.074091
IL-16 3318.95361745.441 1352.526793.1329 0.086079
IP-10/CXCL10 2788.1256638.7175 2083.756386.1531 0.108032
IL-13 1155.2846510.6158 691.01856214.8835 0.144738
IL-7 303.4743643.92227 225.9394684.65913 0.155096
TGF-beta 1 1258.2646579.7825 809.38936276.8387 0.21181
TNF-alpha 665.37256253.2047 470.32946125.4151 0.216649
IL-15 1105.6636490.0397 747.07516298.3578 0.25783
IL-12 p40 278.89936244.9954 132.2073620.76634 0.277818
IL-1alpha 789.19846389.7232 501.77836296.2249 0.284774
MIP-1beta/CCL4 6802.41610969.83 411.36086269.8152 0.288293
GM-CSF 646.39576181.013 487.86816213.2812 0.300297
MIP-1alpha/CCL3 1565.80462724.014 145.5518657.88581 0.33734
Eotaxin/CCL11 337.6356214.8732 207.85086145.9365 0.356223
IL-1beta 347.09886464.1977 118.85625.54739 0.364057
MIP-1-delta/CCL15 4775.70268371.438 738.11736381.3618 0.372454
IL-11 209.94096130.9967 126.02736115.9656 0.374464
G-CSF 166.841267.549383 183.6784638.35403 0.422074
TNF-beta 666.49186197.8449 557.20636168.022 0.432028
TIMP-2 4451.7566831.38 8885.0369518.633 0.477841
sTNF-RI 187.0326149.1322 146.2441650.03695 0.622608
sTNF RII 6674.67961196.531 6295.14161381.866 0.692384
IL-4 54.4984168.085172 65.69883655.71437 0.704477
ICAM-1 1604.13562342.114 2198.59961883.139 0.706074
IL-2 570.71786172.9008 512.41966239.7293 0.706871
IL-3 437.46086113.2187 461.0945675.28243 0.739974
IL-10 1111.496558.5364 975.81326682.902 0.7688
IL-17 206.5566675.81097 179.99746158.1352 0.772196
IL-12 p70 104.0271656.58202 109.7565624.16727 0.858393
Eotaxin-2/CCL24 267.05516235.2759 272.86586228.7234 0.972896
IL-6 R 6293.62662664.849 6248.49561029.621 0.975819
M-CSF 111.9243648.51104 110.8315656.15117 0.977457
doi:10.1371/journal.pone.0056815.t001
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chemokine network in TB-PEs. The Th1-type chemokines have
been shown critical for the accumulation of CD4+ Th1 cells in TB-
PEs which in turn are essential for Mtb containment[32]. Platelet-
derived growth factor (PDGF)-BB is one of the five different
isoforms of PDGF, which include A (PDGFA), B (PDGFB), C
(PDGFC), D (PDGFD), and an AB heterodimer. Cellular
responses are mediated by two different receptors, namely alpha
(PDGFRA) and beta (PDGFRB). Production of PDGF-B by
macrophages is considered central to pathogenesis of TB diseases
involving chronic lung inflammation, which develops into fibrosis
as a consequence of enhanced fibroblast proliferation and
activation. Mycobacterial antigen-stimulated lymphocytes release
IFN-c, which in turn results in increased PDGF-B mRNA in
alveolar macrophages [33]. The fibrogenic PDGF-BB decreases in
serum after chemotherapy and is correlated with fibrosis [34].
These findings offer an explanation for the progression of chronic
inflammation to fibrosis, as it occurs in the lungs of patients with
untreated pulmonary TB [23,35]. The high expression of PDGF-
BB in TB-PEs shown here indicates its fundamental role in TB
disease evolution and suggests its potential value for differential
diagnosis of TB-PEs.
Mediators, including IFN-c and adenosine deaminase (ADA)
have been proposed as markers for differential diagnosis of PEs
[36]. The estimated sum of sensitivity of IFN-c was 89% (95%
confidence interval, CI, 87–91%) and of specificity was 97% (CI,
96–98%). Apparently, these values are superior to published
diagnostic accuracy of ADA [23,35]. So far, alternative markers
with similar or superior diagnostic power have not been identified.
The responses of MCP-2/CCL8 to Mtb-specific antigens have
been used for diagnosis of TB [37]. However, to our knowledge,
the current study is the first to determine the discriminatory power
of spontaneous MCP-2/CCL8 for TB-PEs versus PEs with the
other etiologies. Intriguingly, we defined the cut-off value of
22.78 pg/ml for MCP-2/CCL8 and of 14.75 pg/ml for IFN-c;
sensitivity and specificity of MCP-2/CCL8 for TB-PEs were both
100%, and thus superior to diagnostic accuracy of IFN-c with
sensitivity of 100% but specificity of 91.7% for TB-PEs. We
therefore suggest MCP-2/CCL8 as diagnostic parameter of TB-
PEs. Due to the relatively small sample size and restricted diversity
of PE etiologies, further prospective studies are required to validate
the diagnostic value of MCP-2/CCL8 in larger cohorts with PEs
of diverse etiologies.
Here we observed that the level of plasma MCP-2/CCL8 in TB
patients is equivalent to those in healthy donors, distinct from the
elevated plasma MCP-2/CCL8 levles in patients with sepsis [38],
which suggested that the special constituents of MTB may be
involved in the induction of MCP-2/CCL8. Though the biological
activity of CCL8/MCP-2 in mice remains unclear, recent report
showed that CCL8/MCP-2 in plasma increases with incidence of
Graft-Versus-Host-Disease(GVHD) which is a complication of
bone-marrow transplantation and the study suggests that MCP-2/
CCL8 is associated with immune response within a living
organism of mouse [39,40]. We have done all experiment with
both mouse and human cells and observed similar phenomena,
suggesting that mouse MCP-2/CCL8 may have functional
similarity with human MCP-2/CCL8.
Although induction of MCP-2/CCL8 in macrophages by
mycobacteria at both transcriptional and protein levels has been
previously reported [18,41], underlying regulatory pathways have
not yet been defined. Here we identify TLR2/PI3K/Akt and p38
signaling as essential pathway in mycobacteria-induced MCP-2/
CCL8 production in macrophages. Our finding is consistent with
a previous report that MCP-2/CCL8 secretion in rheumatoid
arthritis synovial fibroblasts is mediated by TLR-2 [42]. Other
studies reported that LPS induces expression of MCP-2/CCL8 in
macrophages via MyD88-dependent signaling [43] and that
poly(I:C) stimulates production of MCP-2/CCL8 in mononuclear
cells[19]. We found that induction of MCP-2/CCL8 by myco-
bacteria only depended on TLR2 but not on TLR3 and TLR4.
These differences are likely due to the different TLR-ligands
studied and mycobacteria are rich in TLR2 agonists including
lipoproteins such as LpdH, LprA, LprG, PhoS1, and glycolipids
such as lipoarabinomannan (LAM), lipomannan (LM), phospha-
tidylinositol mannoside (PIM) and trehalose dimycolate (TDM)
[44].
Chemokines and their receptors orchestrate leukocyte traffick-
ing into and from lymphoid organs and tissues and hence are key
regulators of immune responses. The TB-PEs are enriched for
CD4+ Th1 cells critical for containment of Mtb. Understanding
mechanisms involved in the selective recruitment of T lympho-
cytes to pathologic sites forms the basis for design of future
intervention strategies. Here we demonstrate that T cells in TB-
PEs highly surface-express CCR5. CCR5 has a promiscuous
ligand-binding repertoire, including MIP1a/CCL3, MIP1b/
CCL4 and RANTES/CCL5. It is the prime receptor used by
MCP-2/CCL8 on activated T cells [21]. It has been reported that
memory T cells obtained from the pleural fluid were shown to
express a battery of homing receptors, including CCR5, which
mediated adhesion of T cells from TB-PEs to activated human
umbilical vein endothelial cells (HUVEC) expressing chemotactic
ligands, which suggested the important role of CCR5 in the
polarization of Th1 cells. [32] We conclude that highly expressed
MCP-2/CCL8 in TB-PEs participates in homing of cells
expressing CCR5. In our studies, CCR5 was expressed on both
CD4+ T cells and CD8+ T cells. Yet, the percentage of CCR5-
expressing CD4+ T cells, but not CD8+ T cells, in TB-PEs was
significantly higher as compared to malignant PEs. Consequently,
we assume that the high expression of MCP-2/CCL8 in TB-PEs
recruited CD4+ T lymphocytes by activating its primary receptor
CCR5. This notion is consistent with a previous report that high
expression of MCP-2/CCL8 in mycoplasma-infected mice medi-
ates recruitment and accumulation of CD4+ Th cells expressing
CCR5 to the lung [45].
In conclusion, we defined soluble mediators in the PEs and
identified MCP-2/CCL8 as valuable diagnostic marker for the
differential diagnosis of PEs from TB and non-TB patients. Our
data demonstrate that induction of MCP-2/CCL8 by mycobac-
teria depends on activation of TLR2/PI3K/Akt and p38 signaling
pathway, and provide guidelines for design of novel diagnostic and
therapeutic measures in TB based on the biomarker MCP-2/
CCL8.
Figure 2. Higher percentage of CCR5-expressing CD4+ T cells in TB-PEs. (A) Representative FACS detection of CD3+, CD4+ and CD8+ cells in
PEs from TB patients. (B–D) Representative FACS detection of the expression of CCR5(B), CCR1 (C) or CCR2 (D) on CD3+, CD4+ and CD8+ cells from TB-
PEs. (E–G) Graph shows the comparison of the percentage of CCR5 (E), CCR1 (F) or CCR2 (G) expressing CD3+,CD4+ and CD8+ cells between TB-PEs
and malignant PEs (n = 6). All the fluorescent antibodies are purchased from ebioscience (San Diego, CA). The fluorescent antibodies are used
according to the manual.*, p,0.05
doi:10.1371/journal.pone.0056815.g002
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Figure 3. Mycobacteria-induced MCP-2/CCL8 expression in macrophages. (A–B) Real-time PCR detection of the production of mcp-2/ccl8
mRNA in murine macrophage cell line Raw264.7 infected with either M. bovis BCG (A) or M. tuberculosis H37Rv (B) at MOI 5 for indicated times; (C–D)
Real-time PCR detection of the production of mcp-2/ccl8 mRNA in primary peritoneal macrophages treated with either M. bovis BCG (C) or M.
tuberculosis H37Rv (D) at MOI 5 for indicated times; (E–F) ELISA of MCP-2/CCL8 protein in THP-1, a human acute monocytic leukemia cell line, infected
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Materials and Methods
Cell Culture and Reagents
The murine macrophage cell line RAW264.7 (American Type
Culture Collection, Manassas, VA) and THP-1 cells, a human
acute monocytic leukemia cell line, were cultured in RPMI 1640,
supplemented with 10% fetal bovine serum (FBS) and antibiotics
(50 U/ml penicillin and 50 mg/ml streptomycin). THP-1 cells
were pretreated with 50 ng/ml PMA (Phorbol-12-myristate-13-
acetate) for 24 h to induce their differentiation before stimulation
with Mtb.
RPMI 1640 medium, DMEM, FBS, penicillin, and streptomy-
cin were purchased from Invitrogen (Shanghai, China). PI3K
inhibitor (LY294002), ERK inhibitor (PD980259), JNK inhibitor
(SP600125), p38 inhibitor (SB203580), nuclear factor-kB inhibitor
(BAY11-7082) were obtained from Enzo Life Sciences (Farming-
dale, NY), inhibitors are used at the concentration of 10 mM or
otherwise indicated.. Abs against p-AKT, p-p38, p-ERK, p-JNK,
p-p65 and actin were obtained from Cell Signaling Technology
(Beverly, MA) and used for western bot with a dilution of 1:1000.
PE or FITC or APC labeled CD3, CD4, CD8 and CCR5
antibodies, AlexaFlour 647 labeled CCR1 and CCR2 as well as
corresponding isotype control antibodies were all purchased from
ebioscience (San Diego, CA). The fluorescent antibodies are used
according to the manual. Normally, 5 ml fluorescent antibodies per
test.
Bacteria
M. bovis BCG and M. tuberculosis H37Rv were grown at 37uC
with shaking in Middlebrook 7H9 broth (Becton Dickinson,
Cockeysville, MD) with 0.05% Tween-80 and 10% oleic acid-
albumin-dextrose-catalase(OADC) enrichment (Becton Dickinson,
Sparks, MD). The bacterial suspension was centrifuged at 2,500 g
for 10 min, and the pellet was suspended in RPMI 1640 plus
2 mM L-glutamine, 0.1 mM non-essential amino acids, 1 mM
sodium pyruvate, and 20 mM sodium bicarbonate (Gibco BRL,
Life Technologies, Grand Island, NY) (CRPMI). Bacteria were
passed twice through a 27-gauge needle to disrupt clumps.
Aliquots of 1 ml were stored at 280 uC for at least 1 day, and the
inoculum was titrated by plating serial dilutions on Middlebrook
7H11 medium plus 10% OADC (both from Becton Dickinson
Co., Sparks, MD).
with either M. bovis BCG (E) or M. tuberculosis H37Rv (F) at MOI 5 for indicated times. (G–H) ELISA of MCP-2/CCL8 protein in human PBMC monocyte-
derived macrophages (MDM) infected with either M. bovis BCG (G) or M. tuberculosis H37Rv (H) at MOI 5 for indicated times. Data shown are
representative of at least three independent experiments. **, p,0.001, *, p,0.05.
doi:10.1371/journal.pone.0056815.g003
Figure 4. Mycobacteria-induced expression of MCP-2/CCL8 is regulated by p38 and PI3K. (A-B) Western blot of the signaling pathways
including p38, JNK, ERK, Akt, NF-kB in mouse primary peritoneal macrophages infected with either M. bovis BCG (A) or M. tuberculosis H37Rv (B) at
MOI 5 for indicated time. Data are representative of three independent experiments. (C) ELISA detection of MCP-2/CCL8 protein in THP-1 cells
infected with M. bovis BCG at MOI 5 for 24 h in the presence of different kinase inhibitors, SB203580 (10 mM), SP600125 (10 mM), PD98059 (10 mM),
LY294002 (10 mM), BAY11-7082 (10 mM). (D) ELISA detection of MCP-2/CCL8 protein in human PBMC monocyte-derived macrophages (MDM) infected
with M. tuberculosis H37Rv at MOI 5 for 24 h in the presence of different kinase inhibitors as indicated in (C). **, p,0.001, *, p,0.05.
doi:10.1371/journal.pone.0056815.g004
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Animals and peritoneal macrophage isolation
TLR22/2, TLR32/2 and TLR42/2 mouse mutants were
originally from Professor S. Akira (Osaka University, Osaka,
Japan) and were backcrossed eight times with C57BL/6. C57/
BL6 mice were used as controls. All the mice were maintained in
the Shanghai Laboratory Animal Center (SLAC, Shanghai,
China), and used at 6 and 8 weeks of age. Peritoneal macrophages
were isolated as described previously [46]. Briefly, mice were
injected i.p. with 2 ml of 4% thioglycollate medium (Sigma-
Aldrich). After 3 days, cells harvested by peritoneal lavage with
cold PBS were allowed to adhere for 2 h and the RPMI 1640
medium was changed to remove non-adherent cells. The
remaining adherent monolayer cells were used as primary
peritoneal macrophages after at least 24 h. Before M. bovis BCG
stimulation, cells were cultured in serum-free RPMI 1640 with
antibiotics for 12 h to minimize the influence of FBS. All cells were
cultured at 37uC in a humidified incubator with 5% CO2.
Subjects
The study protocol was approved by the Medical School of
Tongji University review boards for human studies, and informed
consent was obtained from all subjects. Thirteen patients (8M/5F,
39.968.4 years) were proven to have TB-PE, as evidenced by
growth of Mtb from pleural fluid or by diagnosis of granulomatous
pleurisy on closed pleural biopsy specimen in the absence of any
evidence of other granulomatous diseases. All TB-PE patients were
anti-human immunodeficiency virus (HIV) antibody-negative and
were recruited from the Shanghai Pulmonary Hospital. Following
Figure 5. Mycobacteria-induced expression of MCP-2/CCL8 through TLR2. (A-B) Real-time PCR of mcp-2/ccl8 mRNA in primary peritoneal
macrophages from wildtype, TLR22/2, TLR32/2, or TLR42/2 mice infected with either M. bovis BCG (A) or M. tuberculosis H37Rv (B) at MOI 5 for 24 h.
(B) Western blot of phosphorylation of Akt and p38 in primary peritoneal macrophages from wildtype or TLR2 KO mice infected with M. bovis BCG at
MOI 5 for indicated times. Data shown are representative of three independent experiments. (D) Densitometric analysis of three independent
experiments as in (C). Data shown are the mean6sem of three independent experiments. **, p,0.001, *, p,0.05.
doi:10.1371/journal.pone.0056815.g005
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TB chemotherapy, the resolution of TB-PE and clinical symptoms
was observed in all patients. At the time of sample collection, none
of the patients had received any TB drug therapy, corticosteroids,
or other non-steroid anti-inflammatory drugs. Twelve patients
(6M/6F, 42.965.4 years) proven to have PEs with other etiologies,
including cancer, pneumonia and PAH, were selected as
comparators.
Human peripheral blood mononuclear cells (PBMC)
purification and monocytes-derived macrophages (MDM)
differentiation
Human PBMC were purified with Lymphoprep solution (AXIS
SCHIELD, Oslo, Norway) according to the manual. Briefly,
10 ml fresh human blood from healthy donors treated with
heparin was collected and diluted with an equal volume of 0.9%
(w/v) NaCl. Then 6 ml of diluted blood was carefully layered over
3 ml of Lymphoprep solution in a 15 ml conical centrifuge tube
and were then centrifuged at 700 g for 30 min. The sharp band at
the plasma/Lymphoprep interface which containing PBMC was
recovered and washed with PBS. Then approximate 56105
PBMC were seeded in 96-well plate and left adhere for 1–2 h. The
adhered cells are isolated monocytes. To allow freshly isolated
monocytes to differentiate into MDM, the cells were cultured in
the presence of 50 ng/ml human recombinant macrophage
colony stimulating factor (M-CSF) for another six days by
changing medium every two days. Normally, more than 95% of
the differentiated cells are CD14+ (Data unshown). Then the cells
were applied to infection by mycobacteria. All cells were cultured
at 37uC in a humidified incubator with 5% CO2.
PEs and serum isolation and enzyme-linked
immunosorbent assay (ELISA)
PEs from TB patients and non-TB patients were collected in
heparin-treated tubes through a standard thoracocentesis technique
within 24 h after hospitalization. Ten ml of peripheral blood was
drawn and centrifuged simultaneously. The supernatant collected
above were analyzed for MCP-2/CCL8 and IFN-c with ELISA
according to the manufacturer’s instructions (Raybiotech Inc.).
Protein array analysis of cytokines
The cytokine concentrations in PEs were determined with
RayBio Human Inflammation Antibody Array 3 (Cat# AAH-
INF-G3-8) according to the manufacturer’s instructions. Briefly,
the glass chip was blocked and 100 ml PE samples were directly
added to the subarray and incubated with array antibody supports,
ensued with incubation with cocktail of biotinylated antibodies and
subsequent incubation with labeled streptavidin. The glass chip
was scanned with Axon GenePix (emission frequency 532 nm) to
detect the fluorescent signals and the fluorescent intensity value
was extracted with array analysis software and analyzed.
RNA preparation, reverse transcription PCR, and
quantitative real-time PCR
For reverse transcription PCR (RT-PCR), total RNA was
isolated using TRIzol reagent (Invitrogen) following the manufac-
Figure 6. Diagram depicting recruitment of T lymphocytes expressing CCR5 in TB-PEs by mycobactera-induced expression of MCP-
2/CCL8 in macrophages. Induction of MCP-2/CCL8 in macrophages by mycobacteria involves activation of TLR2/PI3K/Akt and p38 signaling.
Highly expressed MCP-2/CCL8 in the TB-PEs may be responsible for the homing of CD4+ T lymphocytes into the infection site by activating the highly
expressed CCR5, the primary receptor used by MCP-2/CCL8.
doi:10.1371/journal.pone.0056815.g006
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turer’s instructions. Reverse transcription was done with the
MMLV Reverse Transcription System (Invitrogen). Primers for
quantitative real-time PCR (qRT-PCR) of the elevated cytokines
in TB-PEs are listed in Table 2. Real-time PCR was run on
Applied Biosystems 7300 Real-time PCR system with SYBRH
Green Real-Time PCR Master Mixes (TOYOBO). All PCR
experiments were done in triplicate within each experiment, and
experiments were replicated at least three times.
Flow cytometry analysis
PEs from patients were centrifuged at 1,000 g for 5 min. The
cell pellets were resuspended with red blood cell (RBC) lysis buffer
to remove RBCs and were then washed twice with PBS and fixed
with 3.7% PFA. Then the cells were aliquoted and 56105 PE cells
suspended in 100 ml staining buffer were mixed with 5 ml
corresponding fluorescent antibodies and keep on ice for
20 min. Then the cells were washed with PBS twice. Flow
cytometry analysis of cell surface markers included CD3, CD4,
CD8, CCR1, CCR2 and CCR5. Samples were then run in the
flow cytometer (BD Accuri C6) and subsequently analyzed with
the BD CFlow Plus software.
Macrophage infection and immunoblot analysis
Peritoneal macrophages were infected with either M. bovis BCG
M. tuberculosis H37Rv at MOI 5 for indicated times. Subsequently,
cells were lysed for 30 min on ice in lysis buffer, followed by
centrifugation at 12,000 g at 4uC for 10 min. After centrifugation,
supernatants were boiled in SDS loading buffer. Equivalent
amounts of proteins were separated on SDS-PAGE under
reducing conditions and were transferred to nitrocellulose
membrane. ECL reagent (Thermo Scientific) was applied in an
immunoblot analysis.
Kinase inhibitors treatment and cytotoxicity assay
Cells were left treated with mock control or different kinase
inhibitors with the concentration indicated 30 min before the
infection of mycobacteria. The cytotoxic effect of these inhibitors
was measured using the CytoTox96 Non-Radioactive Cytotoxicity
Assay (Promega) according to the standard protocol, which is
based on the detection of lactate dehydrogenase (LDH) released
from damaged cells. The percent cytotoxicity was calculated as
1006Spontaneous/Maximum.
Statistical Analysis
All data are expressed as mean 6 SEM. Differences between
groups were analyzed by the Student’s t-test. Values of p,0.05
represented a statistically significant difference.
Supporting Information
Figure S1 Mycobacteria-induced cytokines expression
in macrophages. Real-time PCR detection of the mRNA of
MCP-1/CCL2 (A), RANTES/CCL5 (B), PDGF-BB (C) and MIG/
CXCL9 in mouse macrophage cell line Raw264.7 cells infected
with M. tuberculosis H37Rv at MOI 5 for indicated time. *, p,0.05.
(TIF)
Figure S2 p38 inhibitor and PI3K inhibitor dose-depen-
dently inhibit MCP-2/CCL8 production in macrophag-
es. ELISA detection of MCP-2/CCL8 protein in THP-1 cells
infected with M. bovis BCG at MOI 5 for 24 h in the presence of
p38 inhibitor (SB203580) and PI3K inhibitor (LY294002) with
indicated concentration. *, p,0.05; **, p,0.001.
(TIF)
Figure S3 Kinase inhibitors don’t show significant
cytotoxic effect on macrophages. The cytotoxic effect of
the different kinase inhibitors, SB203580 (10 mM), SP600125
(10 mM), PD98059 (10 mM), LY294002 (10 mM), BAY11-7082
(10 mM), on PMA-differentiated THP-1 cells (A) and PBMC
monocyte-derived macrophages (MDMs) (B) was measured by
detecting the release of lactate dehydrogenase (LDH) from
damaged cells incubated with above inhibitors for 24 h.
(TIF)
Figure S4 Activation of p38 is essential for mycobacte-
ria-inducedmcp-2/ccl8mRNA expression. Real-time PCR
detection of mcp-2/ccl8 mRNA in murine macrophage cell line
Raw264.7 cells infected with M. bovis BCG at MOI 5 for 24 h in
the presence of kinase inhibitors, SB203580 (10 mM), SP600125
(10 mM), PD98059 (10 mM), LY294002 (10 mM), BAY11-7082
(10 mM). *, p,0.05.
(TIF)
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